CFDE Data Portal | Search PLA2G5

	Label	Description
	PLA2G5 associations Collection (Entity type)	Associations for PLA2G5_associations
	PLA2G5 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	PLA2G5 Gene (Entity type)	ENSG00000127472 - phospholipase A2 group V
	GSE120210 GSE120214 TBXT brachyury inhibition 4 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE125862 2 V 1 DEXAMETHASONE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 15 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE119978,GSE180930 0 V 4 CISPLATIN HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE56010 adenosine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228106 3 V 2 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE172458 0 V 1 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

PLA2G5 associations

Associations for PLA2G5_associations

PLA2G5 associations.tsv

A file from IDG as part of the Harmonizome project

PLA2G5

ENSG00000127472 - phospholipase A2 group V

GSE120210 GSE120214 TBXT brachyury inhibition 4 v 0 human dn

A Gene Set from LINCS

GSE125862 2 V 1 DEXAMETHASONE HUMAN UP

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 15 human up

A Gene Set from LINCS

GSE119978,GSE180930 0 V 4 CISPLATIN HUMAN UP

A Gene Set from LINCS

GSE56010 adenosine 4 v 1 human dn

A Gene Set from LINCS

GSE228106 3 V 2 PACLITAXEL HUMAN UP

A Gene Set from LINCS

GSE172458 0 V 1 CISPLATIN HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.